{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:43:29Z","timestamp":1790952209288,"version":"4.1.0"},"update-to":[{"DOI":"10.1016\/j.ijbiomac.2024.133323","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000}}],"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ijbiomac.2024.133323","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T03:04:05Z","timestamp":1718852645000},"page":"133323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"P1","title":["RETRACTED: Expression of transferrin receptor\/TFRC protein in bladder cancer cell T24 and its role in inducing iron death in bladder cancer"],"prefix":"10.1016","volume":"274","author":[{"given":"Junkai","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lize","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133323_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"02","key":"10.1016\/j.ijbiomac.2024.133323_bb0010","first-page":"90","article-title":"Etc trend of incidence rate of bladder cancer in China from 1990 to 2019 [J]","volume":"46","author":"Xincan","year":"2023","journal-title":"Journal of Jining Medical College"},{"key":"#cr-split#-10.1016\/j.ijbiomac.2024.133323_bb0015.1","unstructured":"Sylvester R J, Rodriguez O, Hernandez V, et al. Erratum to \"European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004\/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel\" [Eur. Urol. 79"},{"key":"#cr-split#-10.1016\/j.ijbiomac.2024.133323_bb0015.2","unstructured":"(4) (2021) 480-488][J]. Eur. Urol., 2023,83(5):e140-e141."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.133323_bb0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/14728214.2017.1336536","article-title":"Emerging drugs for urothelial (bladder) cancer[J]","volume":"22","author":"Cumberbatch","year":"2017","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133323_bb0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11596-023-2814-6","article-title":"Current and potential roles of Ferroptosis in bladder Cancer[J]","volume":"44","author":"An","year":"2024","journal-title":"Curr Med Sci"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133323_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41585-018-0105-y","article-title":"T1 bladder cancer: current considerations for diagnosis and management[J]","volume":"16","author":"Jordan","year":"2019","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133323_bb0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder Cancer (ta, T1, and carcinoma in situ)[J]","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.133323_bb0040","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1158\/1078-0432.CCR-15-1135","article-title":"New strategies in bladder Cancer: a second coming for immunotherapy[J]","volume":"22","author":"Ghasemzadeh","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133323_bb0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.urolonc.2016.10.004","article-title":"A review of the PD-1\/PD-L1 checkpoint in bladder cancer: from mediator of immune escape to target for treatment[J]","volume":"35","author":"Zhou","year":"2017","journal-title":"Urol. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.133323_bb0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.clgc.2013.11.016","article-title":"Cisplatin-ineligible and chemotherapy-ineligible patients should be the focus of new drug development in patients with advanced bladder cancer[J]","volume":"12","author":"Sonpavde","year":"2014","journal-title":"Clin. Genitourin. Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133323_bb0055","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1097\/MJT.0000000000000934","article-title":"Immunotherapy in bladder Cancer[J]","volume":"29","author":"Konala","year":"2022","journal-title":"Am. J. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133323_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00262-019-02443-4","article-title":"Mechanisms of immune evasion in bladder cancer[J]","volume":"69","author":"Crispen","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.133323_bb0065","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/14737140.2023.2265572","article-title":"Immunotherapy in urothelial cancer: current status and future directions[J]","volume":"23","author":"Piombino","year":"2023","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133323_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-19-0582","article-title":"Antibody-drug conjugates: a comprehensive review[J]","volume":"18","author":"Khongorzul","year":"2020","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.133323_bb0075","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.133323_bb0080","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1007\/s00204-022-03317-y","article-title":"Ferroptosis as a mechanism of non-ferrous metal toxicity[J]","volume":"96","author":"Aschner","year":"2022","journal-title":"Arch. Toxicol."},{"issue":"1\u20133","key":"10.1016\/j.ijbiomac.2024.133323_bb0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/ars.2021.0136","article-title":"Tetrahydrobiopterin in cell function and death mechanisms","volume":"37","author":"Vasquez-Vivar","year":"2022","journal-title":"Antioxid. Redox Signal."},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.133323_bb0090","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications[J]","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"51","key":"10.1016\/j.ijbiomac.2024.133323_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904197","article-title":"Recent Progress in Ferroptosis inducers for Cancer therapy[J]","volume":"31","author":"Liang","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ijbiomac.2024.133323_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101407","article-title":"Neuronal vulnerability to fetal hypoxia-reoxygenation injury and motor deficit development relies on regional brain tetrahydrobiopterin levels","volume":"29","author":"Vasquez-Vivar","year":"2020","journal-title":"Redox Biol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2024.133323_bb0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4[J]","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133323_bb0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic[J]","volume":"30","author":"Chan","year":"2019","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.133323_bb0115","article-title":"Emerging strategies of Cancer therapy based on Ferroptosis[J]","volume":"30","author":"Shen","year":"2018","journal-title":"Adv. Mater."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.133323_bb0120","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166647","article-title":"RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F\/ACSL4 axis[J]","volume":"133","author":"Wang","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2024.133323_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.09.014","article-title":"KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma[J]","volume":"522","author":"Lu","year":"2021","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.133323_bb0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion[J]","volume":"19","author":"Friedmann","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2024.133323_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.590226","article-title":"Iron metabolism in Ferroptosis[J]","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133323_bb0140","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","article-title":"Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells[J]","volume":"15","author":"Yang","year":"2008","journal-title":"Chem. Biol."},{"issue":"7769","key":"10.1016\/j.ijbiomac.2024.133323_bb0145","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","article-title":"Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling[J]","volume":"572","author":"Wu","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.133323_bb0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41419-017-0043-2","article-title":"Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields[J]","volume":"9","author":"Martin-Sanchez","year":"2018","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.133323_bb0155","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","article-title":"Transferrin receptor is a specific Ferroptosis marker[J]","volume":"30","author":"Feng","year":"2020","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133323_bb0160","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","article-title":"Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells[J]","volume":"15","author":"Yang","year":"2008","journal-title":"Chem. Biol."},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.133323_bb0165","doi-asserted-by":"crossref","first-page":"8675","DOI":"10.1245\/s10434-023-14053-7","article-title":"Transferrin receptor is associated with sensitivity to Ferroptosis inducers in hepatocellular carcinoma[J]","volume":"30","author":"Hiromatsu","year":"2023","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.133323_bb0170","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41419-021-03790-w","article-title":"MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma[J]","volume":"12","author":"Lu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.133323_bb0175","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41419-023-06114-2","article-title":"Knockdown of ANXA10 induces ferroptosis by inhibiting autophagy-mediated TFRC degradation in colorectal cancer[J]","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.133323_bb0180","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.7150\/ijbs.74546","article-title":"PHGDH inhibits Ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder Cancer[J]","volume":"18","author":"Shen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.133323_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.17855","article-title":"FLRT2 suppresses bladder cancer progression through inducing ferroptosis[J]","volume":"28","author":"Jiang","year":"2023","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133323_bb0190","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12935-021-02096-3","article-title":"A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration[J]","volume":"21","author":"Luan","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133323_bb0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/nyas.13008","article-title":"Iron and cancer: recent insights[J]","volume":"1368","author":"Manz","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2024.133323_bb0200","doi-asserted-by":"crossref","first-page":"1040892","DOI":"10.3389\/fonc.2022.1040892","article-title":"Systematical analysis of ferroptosis regulators and identification of GCLM as a tumor promotor and immunological biomarker in bladder cancer[J]","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"issue":"3\u20134","key":"10.1016\/j.ijbiomac.2024.133323_bb0205","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10495-023-01817-5","article-title":"m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation[J]","volume":"28","author":"Wang","year":"2023","journal-title":"Apoptosis"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.133323_bb0210","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12033-020-00269-5","article-title":"m6A RNA methylation: ramifications for gene expression and human health[J]","volume":"62","author":"Karthiya","year":"2020","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.133323_bb0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.freeradbiomed.2022.06.247","article-title":"Loss of EMP1 promotes the metastasis of human bladder cancer cells by promoting migration and conferring resistance to ferroptosis through activation of PPAR gamma signaling[J]","volume":"189","author":"Liu","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.133323_bb0220","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/mc.23533","article-title":"PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradation[J]","volume":"62","author":"Luo","year":"2023","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ijbiomac.2024.133323_bb0225","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2021.08.232","article-title":"Mitochondrial dysfunction in mouse livers depleted of iron chaperone PCBP1[J]","volume":"175","author":"Jadhav","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133323_bb0230","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/hep.31328","article-title":"Iron chaperone poly rC binding protein 1 protects mouse liver from lipid peroxidation and steatosis[J]","volume":"73","author":"Protchenko","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2024.133323_bb0235","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.2147\/IJGM.S339996","article-title":"Novel Ferroptosis-related multigene prognostic models for patients with bladder Cancer[J]","volume":"14","author":"Zhang","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.ijbiomac.2024.133323_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102509","article-title":"Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model[J]","volume":"57","author":"Pei","year":"2022","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133323_bb0245","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1007\/s12035-022-02738-1","article-title":"Exosome-derived lncRNA NEAT1 exacerbates Sepsis-associated encephalopathy by promoting Ferroptosis through regulating miR-9-5p\/TFRC and GOT1 Axis[J]","volume":"59","author":"Wei","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2024.133323_bb0250","doi-asserted-by":"crossref","first-page":"1066885","DOI":"10.3389\/fmolb.2023.1066885","article-title":"Characterization and role exploration of ferroptosis-related genes in osteoarthritis[J]","volume":"10","author":"Wang","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.133323_bb0255","first-page":"163","article-title":"Upregulation of SOCS2 causes mitochondrial dysfunction and promotes ferroptosis in pancreatic cancer cells[J]","volume":"70","author":"He","year":"2023","journal-title":"Acta Biochim. Pol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.133323_bb0260","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s13577-023-00890-x","article-title":"Promotion of ferroptosis in head and neck cancer with divalent metal transporter 1 inhibition or salinomycin[J]","volume":"36","author":"Lee","year":"2023","journal-title":"Hum. Cell"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.133323_bb0265","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s41374-022-00826-3","article-title":"CircRNA-ST6GALNAC6 increases the sensitivity of bladder cancer cells to erastin-induced ferroptosis by regulating the HSPB1\/P38 axis[J]","volume":"102","author":"Wang","year":"2022","journal-title":"Lab. Invest."},{"issue":"7769","key":"10.1016\/j.ijbiomac.2024.133323_bb0270","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","article-title":"Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling[J]","volume":"572","author":"Wu","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.133323_bb0275","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-020-1086-y","article-title":"Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma[J]","volume":"26","author":"Gao","year":"2020","journal-title":"Nat. Med."},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.133323_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133181","article-title":"Advances in diagnosis and therapy for bladder Cancer[J]","volume":"14","author":"Hu","year":"2022","journal-title":"Cancers (Basel)"}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2024.133323","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000}},{"DOI":"10.1016\/j.ijbiomac.2026.153488","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000}},{"DOI":"10.1016\/j.ijbiomac.2026.153488","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"record-id":"72041"},{"DOI":"10.1016\/j.ijbiomac.2026.153488","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302404128X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302404128X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T19:36:18Z","timestamp":1789328178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302404128X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":57,"alternative-id":["S014181302404128X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.133323","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Expression of transferrin receptor\/TFRC protein in bladder cancer cell T24 and its role in inducing iron death in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.133323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"133323"}}